Development of Methamphetamine Conjugated Vaccine through Hapten Design: In Vitro and In Vivo Characterization.

We successfully developed and characterized a novel METH vaccine in vitro and in vivo. The present study findings are encouraging and will form the basis of further exploration to assess its effectiveness to prevent METH addiction in preclinical models.